Clinical Study
Alkaline Phosphatase: The Next Independent Predictor of the Poor 90-Day Outcome in Alcoholic Hepatitis
Table 2
Baseline scoring systems values of the study population (
)
#.
| | Survivors () | Nonsurvivors () | | Mean | SD | Median | q25–q75 | Mean | SD | Median | q25–q75 |
| ABIC** | 7.02 | 1.15 | 7.01 | 6.23–7.78 | 7.97 | 1.17 | 8.15 | 6.96–8.60 | GAHS*** | 7.44 | 1.16 | 7.00 | 7.00-8.00 | 9.15 | 1.78 | 9.50 | 8.00–10.00 | MELD*** | 17.74 | 4.90 | 16.00 | 15.00–19.75 | 22.80 | 7.28 | 22.50 | 18.00–28.00 | MELD-Na*** | 20.40 | 7.15 | 19.00 | 17.00–22.00 | 27.70 | 7.25 | 26.00 | 22.50–31.00 | CPT*** | 9.00 | 1.69 | 9.00 | 7.00–10.00 | 11.05 | 1.36 | 11.00 | 10.50–12.00 | mDF*** | 21.11 | 17.66 | 15.00 | 10.03–27.10 | 46.78 | 34.77 | 32.00 | 20.00–68.71 |
|
|
; .
#ABIC: Age, Bilirubin, INR, Creatinine score; CPT: Child-Pugh-Turcotte score; GAHS: Glasgow Alcoholic Hepatitis Score; mDF: modified Maddrey's discriminant function; MELD: Model for End-Stage Liver Disease; q25: first quartile; q75: third quartile.
|